$GNCA (ASCO dark horse)009 cancer vax combo pd1 data due @ ASCO must b promising as they plan to start a monotherapy trial w it according to their Needham presentation yday. $GSK &amp; $JNJ both own sizable positions in $GNCA.  Looking forward to data from: $TRIL $GNCA $VSTM